<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Takeda Pharmaceuticals</title>
    <link>http://www.newstin.co.uk/uk/TAKEDA_PHARMACEUTICALS</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Takeda Pharmaceuticals - News</title>
      <link>http://www.newstin.co.uk/uk/TAKEDA_PHARMACEUTICALS</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Thu, 26 Nov 2009 15:34:04 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/TAKEDA_PHARMACEUTICALS</guid>
      <dc:date>2009-11-26T15:34:04Z</dc:date>
    </item>
    <item>
      <title>Records show White House health care talks</title>
      <link />
      <description />
      <pubDate>Wed, 25 Nov 2009 18:40:31 GMT</pubDate>
      <guid />
      <dc:date>2009-11-25T18:40:31Z</dc:date>
    </item>
    <item>
      <title>TAK-438 Enters Phase II Clinical Trialsfor the Treatment of Reflux Esophagitis</title>
      <link />
      <description />
      <pubDate>Mon, 23 Nov 2009 11:01:27 GMT</pubDate>
      <guid />
      <dc:date>2009-11-23T11:01:27Z</dc:date>
    </item>
    <item>
      <title>Four Senior Executives Join Orexigen(R) Therapeutics Management Team</title>
      <link />
      <description />
      <pubDate>Mon, 23 Nov 2009 14:36:16 GMT</pubDate>
      <guid />
      <dc:date>2009-11-23T14:36:16Z</dc:date>
    </item>
    <item>
      <title>Research and Markets: Strategies for Building Early-Stage Pharmaceutical Pipelines Through...</title>
      <link />
      <description />
      <pubDate>Fri, 20 Nov 2009 16:36:07 GMT</pubDate>
      <guid />
      <dc:date>2009-11-20T16:36:07Z</dc:date>
    </item>
    <item>
      <title>Sucampo Receives Marketing Authorization for Amitiza® in Switzerland for Treatment of Chronic...</title>
      <link />
      <description />
      <pubDate>Thu, 19 Nov 2009 21:10:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-19T21:10:00Z</dc:date>
    </item>
    <item>
      <title>Research and Markets: Cancer Therapies - Global Market Opportunities</title>
      <link />
      <description />
      <pubDate>Thu, 19 Nov 2009 13:54:04 GMT</pubDate>
      <guid />
      <dc:date>2009-11-19T13:54:04Z</dc:date>
    </item>
    <item>
      <title>XOMA Appoints Jim Neal Vice President of Business Development</title>
      <link />
      <description />
      <pubDate>Tue, 17 Nov 2009 13:00:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-17T13:00:00Z</dc:date>
    </item>
    <item>
      <title>Another Win for Mylan (Zacks.com)</title>
      <link />
      <description />
      <pubDate>Fri, 13 Nov 2009 17:55:55 GMT</pubDate>
      <guid />
      <dc:date>2009-11-13T17:55:55Z</dc:date>
    </item>
    <item>
      <title>XOMA 052 Selected as a Top Ten Project to Watch</title>
      <link />
      <description />
      <pubDate>Thu, 12 Nov 2009 20:17:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-12T20:17:00Z</dc:date>
    </item>
  </channel>
</rss>

